GenoScreen in La Gazette of Nord-Pas de Calais

Discover La Gazette Nord-Pas de Calais article about our company "GenoScreen dissects DNA"

pdfgazette-nord-pas-de-calais-janvier-2018.pdf206.33 KB18.pdf

Become a GenoScreen Team Member

Join the GenoScreen team, we are looking for a Technical Sales Engineer, Genomics Specialty, apply!

GenoScreen's ISO certifications confirmed

Bureau Veritas Certification has renewed GenoScreen's ISO 9001:2015 and ISO 13485:2016 certifications for 3 years, demonstrating our continuous commitment to quality and efforts to satisfy our customers as best as possible, in compliance with legal and regulatory requirements.

How do genomics and genotyping contribute to species preservation?

Biodiversity, species preservation, ecosystem protection...
All are hot topics to which GenoScreen's genotyping solutions provide answers.

A new positive evaluation of Deeplex® Myc-TB

The innovative Deeplex® Myc-TB test for antibiotic resistance prediction in tuberculosis, created by GenoScreen, has been evaluated by an Indian research team. By testing approximately 40 clinical samples, this study validates the use of Deeplex® Myc-TB, by demonstrating its usability in hospital environments. These results confirm the interest of its deployment in hospital routines for the benefit of patients' health.

Next trainings

Sign up for our command line trainings at NGS data analysis from October 7 to 10, 2019.

 Training schedule

Meet us at Mycobacteria 2019 congress

GenoScreen will participate in the Mycobacteria 2019 congress on June 26, 27 and 28 in Angers.

Subcategories

GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.

Our projects are designed to:

  • Improve the diagnosis and management of acute/chronic diseases on humans and animals,
  • Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.

The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.

By continuing your visit to this site, you accept the use of statistics cookies